Narrow search
Showing 1 - 10 of 286
Cover Image
The Welfare Effects of Public Drug Insurance
Lakdawalla, Darius N. - 2007
Rewarding inventors with inefficient monopoly power has long been regarded as the price of encouraging innovation. Public prescription drug insurance escapes that trade-off and achieves an elusive goal: lowering static deadweight loss, while simultaneously encouraging dynamic investments in...
Persistent link: https://www.econbiz.de/10012775801
Cover Image
The Welfare Effects of Public Drug Insurance
Lakdawalla, Darius - 2007
Rewarding inventors with inefficient monopoly power has long been regarded as the price of encouraging innovation. Public prescription drug insurance escapes that trade-off and achieves an elusive goal: lowering static deadweight loss, while simultaneously encouraging dynamic investments in...
Persistent link: https://www.econbiz.de/10012465145
Cover Image
An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending
Vernon, John A.; Golec, Joseph; Lutter, Randall W.; … - In: The quarterly review of economics and finance : journal … 49 (2009) 4, pp. 1260-1274
Persistent link: https://www.econbiz.de/10003903758
Cover Image
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina; Gurdgiev, Constantin - In: Applied economics letters 23 (2016) 4/6, pp. 278-283
Persistent link: https://www.econbiz.de/10011430453
Cover Image
The future of drug development : the economics of pharmacogenomics
Vernon, John A.; Hughen, W. Keener - 2005
Persistent link: https://www.econbiz.de/10003262033
Cover Image
Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending
Golec, Joseph; Hedge, Shantaram; Henderson, J. Vernon - 2005
Persistent link: https://www.econbiz.de/10002717615
Cover Image
The $800 million pill : the truth behind the cost of new drugs
Goozner, Merrill - 2004
Persistent link: https://www.econbiz.de/10001803092
Cover Image
Price markups and R&D inputs : the pharmaceutical industry in Finland and the USA
Hermans, Raine (contributor); Linnosmaa, Ismo (contributor) - 2003 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10001815876
Cover Image
Health policy and technological change
Finkelstein, Amy - 2003
Persistent link: https://www.econbiz.de/10001730335
Cover Image
Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
Golec, Joseph H. - 2010
legalized reimportation of lower-priced pharmaceuticals from foreign countries. This study uses the Clinton Administration …
Persistent link: https://www.econbiz.de/10012762479